Medicine & Health

Deborah Veis, MD, PhD, professor of medicine in the Division of Bone and Mineral Diseases at the School of Medicine, has been appointed the next editor-in-chief of the Journal of Bone and Mineral Research Plus. Her five-year term begins Sept. 1.

The McKelvey School of Engineering’s Nathaniel Huebsch will use a nearly $2 million grant from the National Institutes of Health (NIH) to study hypertrophic cardiomyopathy, the most common cause of sudden death in young people.

A new, drug-free technology developed in the lab of Jianjun Guan at the McKelvey School of Engineering helps speed up the healing process of diabetic wounds.

A team from the McKelvey School of Engineering and the School of Medicine will use a $3.12 million grant to improve brain imaging to better understand stroke recovery.

As tensions continue to run high in the Middle East, a new study from the Brown School finds that adolescents from the conflict-affected region who are residing in the United States have lower levels of resilience and a heightened risk of suicide ideation compared to their American-born peers.

New research from physicists in Arts & Sciences reveals that neurons in the visual cortex — the part of the brain that processes visual stimuli — respond differently to the same kind of stimulus over time.

Applications are being accepted for the Specialized Programs of Research Excellence (SPORE) in Leukemia Career Enhancement Program. Interested junior researchers should apply by Sept. 15.

Researchers at Washington University School of Medicine have found clues to how lung damage develops in the aftermath of a respiratory infection. The findings, published in the Journal of Clinical Investigation, reveal potential interventions to prevent such chronic lung damage.

Kenan Omurtag, MD, an accomplished fertility specialist, educator and mentor, has been named director of the Division of Reproductive Endocrinology & Infertility in the Department of Obstetrics & Gynecology at Washington University School of Medicine.

School of Medicine scientists have identified an antibody that is highly protective against a broad range of COVID-19 viral variants.